ARTICLE | Management Tracks
Plus: Junshi COO Hui departing, Kaufmann named CSO at Hansa
By Richard Guy, Biopharma Analyst, and Gunjan Ohri, Data Content Analyst
September 1, 2023 11:04 PM UTC
Ipsen Group (Euronext:IPN; Pink:IPSEY) named Christelle Huguet to succeed EVP and Head of R&D Howard Mayer, who is retiring effective Sept. 22. Huguet joined Ipsen in May 2020 as SVP and head of research, external innovation and early development from X-Chem Inc., where she was CSO. Prior to X-Chem, Huguet was head of internal research at Alexion Pharmaceuticals Inc.
Zhang Zhuobing and Yao Sheng will assume COO duties at Shanghai Junshi Biosciences Co. Ltd. (HKEX:1877; Shanghai:688180), following the departure of COO Feng Hui for personal reasons. The company added that it will retain Hui as a technical consultant, to ensure a smooth transition. …
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Automotive / EVs, Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- ChartPrime. Elevate your Trading Game with ChartPrime. Access Here.
- BlockOffsets. Modernizing Environmental Offset Ownership. Access Here.
- Source: https://www.biocentury.com/article/649119/huguet-to-succeed-mayer-at-ipsen